Literature DB >> 19648401

Reduction in fragile X related 1 protein causes cardiomyopathy and muscular dystrophy in zebrafish.

Sandra Van't Padje1, Bill Chaudhry, Lies-Anne Severijnen, Herma C van der Linde, Edwin J Mientjes, Ben A Oostra, Rob Willemsen.   

Abstract

Lack of the FMR1 gene product causes fragile X syndrome, the commonest inherited cause of mental impairment. We know little of the roles that fragile X related (FXR) gene family members (FMR1, FXR2 and FXR1) play during embryonic development. Although all are expressed in the brain and testis, FXR1 is the principal member found in striated and cardiac muscle. The Fxr1 knockout mice display a striated muscle phenotype but it is not known why they die shortly after birth; however, a cardiac cause is possible. The zebrafish is an ideal model to investigate the role of fxr1 during development of the heart. We have carried out morpholino knockdown of fxr1 and have demonstrated abnormalities of striated muscle development and abnormal development of the zebrafish heart, including failure of looping and snapping of the atrium from its venous pole. In addition, we have measured cardiac function using high-speed video microscopy and demonstrated a significant reduction in cardiac function. This cardiac phenotype has not been previously described and suggests that fxr1 is essential for normal cardiac form and function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19648401     DOI: 10.1242/jeb.032532

Source DB:  PubMed          Journal:  J Exp Biol        ISSN: 0022-0949            Impact factor:   3.312


  24 in total

1.  FXR1P but not FMRP regulates the levels of mammalian brain-specific microRNA-9 and microRNA-124.

Authors:  Xia-Lian Xu; Ruiting Zong; Zhaodong Li; Md Helal Uddin Biswas; Zhe Fang; David L Nelson; Fen-Biao Gao
Journal:  J Neurosci       Date:  2011-09-28       Impact factor: 6.167

2.  FXR1 is elevated in colorectal cancer and acts as an oncogene.

Authors:  Xin Jin; Bo Zhai; Taishi Fang; Xiaohui Guo; Lishan Xu
Journal:  Tumour Biol       Date:  2015-09-24

3.  Fragile X mental retardation protein has a unique, evolutionarily conserved neuronal function not shared with FXR1P or FXR2P.

Authors:  R Lane Coffee; Charles R Tessier; Elvin A Woodruff; Kendal Broadie
Journal:  Dis Model Mech       Date:  2010-05-04       Impact factor: 5.758

4.  Desmoplakin and talin2 are novel mRNA targets of fragile X-related protein-1 in cardiac muscle.

Authors:  Samantha A Whitman; Cathleen Cover; Lily Yu; David L Nelson; Daniela C Zarnescu; Carol C Gregorio
Journal:  Circ Res       Date:  2011-06-09       Impact factor: 17.367

Review 5.  Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery.

Authors:  Udai Bhan Pandey; Charles D Nichols
Journal:  Pharmacol Rev       Date:  2011-03-17       Impact factor: 25.468

6.  Reactivation of fetal splicing programs in diabetic hearts is mediated by protein kinase C signaling.

Authors:  Sunil K Verma; Vaibhav Deshmukh; Patrick Liu; Curtis A Nutter; Rosario Espejo; Ming-Lung Hung; Guey-Shin Wang; Gene W Yeo; Muge N Kuyumcu-Martinez
Journal:  J Biol Chem       Date:  2013-10-22       Impact factor: 5.157

7.  Short- and long-term memory are modulated by multiple isoforms of the fragile X mental retardation protein.

Authors:  Paromita Banerjee; Brian P Schoenfeld; Aaron J Bell; Catherine H Choi; Michael P Bradley; Paul Hinchey; Maria Kollaros; Jae H Park; Sean M J McBride; Thomas C Dockendorff
Journal:  J Neurosci       Date:  2010-05-12       Impact factor: 6.167

8.  Developmentally regulated alternative splicing is perturbed in type 1 diabetic skeletal muscle.

Authors:  Curtis A Nutter; Elizabeth Jaworski; Sunil K Verma; Yareli Perez-Carrasco; Muge N Kuyumcu-Martinez
Journal:  Muscle Nerve       Date:  2017-04-17       Impact factor: 3.217

Review 9.  Alternative splicing and muscular dystrophy.

Authors:  Mariaelena Pistoni; Claudia Ghigna; Davide Gabellini
Journal:  RNA Biol       Date:  2010-07-01       Impact factor: 4.652

Review 10.  Fragile hearts: new insights into translational control in cardiac muscle.

Authors:  Daniela C Zarnescu; Carol C Gregorio
Journal:  Trends Cardiovasc Med       Date:  2013-04-10       Impact factor: 6.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.